Video
In this video, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
In this video shot at BIO International Convention 2013, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
FDA Approves Bimekizumab-Bkzx as Treatment for Hidradenitis Suppurativa